Respiratory Syncytial Virus, Human
"Respiratory Syncytial Virus, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.
Descriptor ID |
D018113
|
MeSH Number(s) |
B04.820.455.600.670.600.750.730
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus, Human".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus, Human".
This graph shows the total number of publications written about "Respiratory Syncytial Virus, Human" by people in this website by year, and whether "Respiratory Syncytial Virus, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
2023 | 2 | 0 | 2 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory Syncytial Virus, Human" by people in Profiles.
-
Ginkgolic acid inhibits orthopneumo- and metapneumo- virus infectivity. Sci Rep. 2024 04 08; 14(1):8230.
-
Seasonality in Respiratory Syncytial Virus Hospitalizations and Immunoprophylaxis. JAMA Health Forum. 2023 Jun 02; 4(6):e231582.
-
Healthcare-Associated Respiratory Syncytial Virus in Children's Hospitals. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):265-272.
-
Dacron swab and PBS are acceptable alternatives to flocked swab and viral transport media for SARS-CoV-2. Diagn Microbiol Infect Dis. 2021 Jan; 99(1):115209.
-
The performance of Luminex ARIES® Flu A/B & RSV and Cepheid Xpert® Flu/RSV XC for the detection of influenza A, influenza B, and respiratory syncytial virus in prospective patient samples. J Clin Virol. 2017 10; 95:84-85.
-
Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. Transpl Infect Dis. 2016 Apr; 18(2):210-5.